档案脑脊液cfDNA靶向测序检测软脑膜转移相关体细胞变异的验证
该研究在25例曾接受肿瘤分子检测的患者中,验证了档案脑脊液cfDNA的靶向二代测序(OncoPanel)检测体细胞变异的性能。结果显示脑脊液储存时间和体积不影响cfDNA浓度或平均靶向覆盖度;细胞学阳性、可疑/非典型和阴性标本中分别有88%、50%和27%检出既往已知的体细胞变异。MRI有软脑膜强化患者中81%检出体细胞变异,无强化者仅31%。
要点
- 脑脊液储存时间和体积不影响cfDNA浓度及测序覆盖度。
- 细胞学阳性、可疑/非典型、阴性标本的变异检出率分别为88%、50%、27%。
- MRI软脑膜强化者变异检出率81%,无强化者31%。
核心结论
- 脑脊液cfDNA稳定,可在细胞学评估后再行二代测序。
- 临床高度怀疑但细胞学或影像学不确定时,脑脊液cfDNA检出致病性体细胞变异可辅助软脑膜转移诊断。
研究设计与样本
- 验证性研究,在25例曾接受肿瘤标本分子检测的患者中,对档案脑脊液cfDNA进行靶向二代测序(OncoPanel)检测体细胞变异。
主要发现
- 脑脊液储存时间和体积对cfDNA浓度或平均靶向覆盖度无影响。
- 细胞学阳性、可疑/非典型、阴性标本中分别有88%、50%、27%检出既往已知的体细胞变异。
- MRI有软脑膜强化患者中81%检出体细胞变异,无强化者31%。
临床怎么用
- 脑脊液标本可先做细胞学评估,再分流进行二代测序。
- 临床高度怀疑软脑膜转移但细胞学或影像学不确定时,可考虑脑脊液cfDNA检测体细胞变异辅助诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Leptomeningeal metastases occur across multiple solid and lymphoid cancers, and patients typically undergo cytopathologic assessment of cerebrospinal fluid (CSF) in this setting. For patients diagnosed with metastatic cancer, the detection of actionable somatic mutations in CSF can provide clinically valuable information for treatment without the need for additional tissue collection. METHODS: The authors validated a targeted next-generation sequencing assay for the detection of somatic variants in cancer (OncoPanel) on cell-free DNA (cfDNA) isolated from archival CSF specimens in a cohort of 25 patients who had undergone molecular testing of a prior tumor specimen. RESULTS: CSF storage time and volume had no impact on cfDNA concentration or mean target coverage of the assay. Previously identified somatic variants in CSF cfDNA were detected in 88%, 50%, and 27% of specimens diagnosed cytologically as positive, suspicious/atypical, and negative for malignancy, respectively. Somatic variants were identified in 81% of CSF specimens from patients who had leptomeningeal enhancement on magnetic resonance imaging compared with 31% from patients without such enhancement. CONCLUSIONS: These data highlight the stability of cfDNA in CSF, which allows for cytopathologic evaluation before triage for next-generation sequencing assays. For a subset of cases in which clinical suspicion is high but cytologic or radiographic studies are inconclusive, the detection of pathogenic somatic variants in CSF cfDNA may aid in the diagnosis of leptomeningeal metastases.
引用
- Neil AJ, Chukwueke UN, Hoover N, et al. Validation of targeted next-generation sequencing of cell-free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involving the leptomeninges: Cytopathologic and radiographic correlation. Cancer Cytopathol. 2023. PMID: 37812603. doi:10.1002/cncy.22768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。